Next Article in Journal
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
Next Article in Special Issue
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
Previous Article in Journal
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
Previous Article in Special Issue
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(2), 178; https://doi.org/10.3390/pharmaceutics13020178
Action Date Notes Link
article pdf uploaded. 28 January 2021 15:15 CET Version of Record https://www.mdpi.com/1999-4923/13/2/178/pdf-vor
article supplementary file uploaded. 28 January 2021 15:15 CET - https://www.mdpi.com/1999-4923/13/2/178#supplementary
article xml file uploaded 3 February 2021 03:03 CET Original file -
article xml uploaded. 3 February 2021 03:03 CET Update https://www.mdpi.com/1999-4923/13/2/178/xml
article pdf uploaded. 3 February 2021 03:03 CET Updated version of record https://www.mdpi.com/1999-4923/13/2/178/pdf
article html file updated 3 February 2021 03:04 CET Original file -
article html file updated 24 July 2022 05:42 CEST Update https://www.mdpi.com/1999-4923/13/2/178/html
Back to TopTop